AI-generated summary
The authors report on one 16-year-old patient with moderate hidradenitis suppurativa treated with a 1726-nm laser on one draining tunnel while on concurrent adalimumab. They describe resolved drainage, improved scar pliability and smaller tunnels on ultrasound on the treated side, and no adverse events. Interpretation is limited by the single case and concurrent biologic therapy.
- Participants
- 1
- Who or what was studied
- One 16-year-old female with moderate hidradenitis suppurativa and Fitzpatrick skin type VI
- Wavelengths
- 1726 nm
- Limits stated in the abstract
- Single patient case report with concurrent adalimumab therapy and no control group; the abstract calls for larger controlled studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.